Status:

UNKNOWN

Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen

Lead Sponsor:

University Hospital, Rouen

Conditions:

Corona Virus Infection

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

At present, the offer of tests for the serological diagnosis of CoVID-19 (detection of IgG, IgM or IgA antibodies against CoV-2 SARS) is plethoric and is based on the use of a very large number of rap...

Eligibility Criteria

Inclusion

  • The inclusion criteria in the retrospective "Negative/Potentially Interfering" group are as follows :
  • Adult patient sampled prior to the onset of the COVID-19 epidemic (before January 2020)
  • Patient presenting a coronavirus infection other than SARS-CoV-2, or other respiratory viral infections (influenza, metapneumovirus)
  • Patients for whom a serum is kept in the biocollection declared under the number AC-2014-2293 and kept in the Institute of Clinical Biology, University Hospital of Rouen.
  • The criteria for inclusion in the "acute point infection" group are as follows:
  • Patients screened by a positive RT-PCR for an SARS-CoV-2 infection
  • Patients aged ≥ 18 years old
  • Patients taken in charge in the emergency room / in a unit / in COVID resuscitation at the Rouen University Hospital.
  • Patients having read and understood the briefing note
  • Non-opposition to participation in the study
  • The criteria for inclusion in the "Sequential acute infection" group are as follows:
  • Patients with positive RT-PCR for CoV-2-SARS infection
  • Patients aged ≥ 18 years old
  • Taken care of in a COVID unit at the Rouen University Hospital
  • Having read and understood the briefing note and signed the informed consent form
  • The criteria for inclusion in the "Convalescent" group are as follows:
  • Caregivers working at the UH of Rouen
  • Screened by positive RT-PCR for SARS-CoV-2 infection,
  • Healed for at least one month at the time of inclusion
  • Having read and understood the briefing note and signed the informed consent form

Exclusion

  • Minor person
  • Known Pregnancy
  • Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / subtutorship or guardianship
  • Person not affiliated with social security
  • Person who does not understand and speak French

Key Trial Info

Start Date :

November 26 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

385 Patients enrolled

Trial Details

Trial ID

NCT04707833

Start Date

November 26 2020

End Date

December 1 2023

Last Update

January 13 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rouen University Hospital

Rouen, France, 760031

Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen | DecenTrialz